Swiss National Bank Praxis Precision Medicines, Inc. Transaction History

Swiss National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$1.75 - $11.34 $57,225 - $370,818	32,700 Added 61.58%	85,800 $210,000
Q1 2022 May 09, 2022	BUY	$10.21 - $20.29 $39,819 - $79,131	3,900 Added 7.93%	53,100 $542,000
Q4 2021 Feb 08, 2022	BUY	$16.76 - $22.99 $20,112 - $27,587	1,200 Added 2.5%	49,200 $969,000
Q2 2021 Aug 06, 2021	BUY	$18.28 - $33.05 $877,440 - $1.59 Million	48,000 New	48,000 $877,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.